About C-RAD
C-RAD is a company based in Uppsala (Sweden) founded in 2004. The company has 9 employees as of December 31, 2022. C-RAD has completed 1 acquisition, including MedAustron. C-RAD offers products and services including Catalyst⁺ HD, Catalyst⁺, and Sentinel 4DCT. C-RAD operates in a competitive market with competitors including On Target Laboratories, Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics, Averto Medical and US Medical Innovations, among others.
- Headquarter Uppsala, Sweden
- Employees 9 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name C-Rad, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$11.08 M (USD), Post-IPO
Feb 19, 2020
-
Investors
TIN Fonder
& 3 more
-
Employee Count
9
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C-RAD
C-RAD offers a comprehensive portfolio of products and services, including Catalyst⁺ HD, Catalyst⁺, and Sentinel 4DCT.
Provides high-precision surface guided radiation therapy for cancer patients
Offers patient positioning and motion management in radiation treatments
Supports accurate imaging for radiation therapy planning
People of C-RAD
Unlock access to complete
Unlock access to complete
Funding Insights of C-RAD
Investors in C-RAD
C-RAD has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include TIN Fonder, Berenberg and Humle Kapitalförvaltning.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment funds are managed focusing on technology and health sectors.
|
Locked | Locked | Locked | |
|
Private bank providing wealth management, corporate banking, and asset management solutions.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for C-RAD
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by C-RAD
C-RAD has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MedAustron.
Investment portfolio details for C-RAD
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Standalone ion therapy and research center
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for C-RAD
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - C-RAD
Detailed financials for C-RAD
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
C-Rad Comparisons
Peer comparison for C-RAD
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of C-RAD
C-RAD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as On Target Laboratories, Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics, Averto Medical and US Medical Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular imaging agents for cancer surgery are developed.
|
|
| Locked | Locked | Locked |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| Locked | Locked | Locked |
Developer of fluorescence-guided imaging technologies to help surgeons detect residual cancer tissue during operations
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal disease patients are developed.
|
|
| Locked | Locked | Locked |
Electrosurgery and plasma technology for cancer treatment are developed.
|
Detailed competitors of C-RAD
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on C-Rad
Complete news archive for C-RAD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about C-RAD
C-RAD was founded in 2004 and raised its 1st funding round 16 years after it was founded.
C-RAD is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
Cecilia De Leeuw is the current CEO of C-RAD.
As of Dec 31, 2022, the latest employee count at C-RAD is 9.
C-RAD was established in 2004 in Uppsala, Sweden, as a standalone oncology treatment clinic. Operations are centered on providing specialized cancer care services, including patient positioning and monitoring solutions for radiation therapy. The company functions within the healthcare sector, focusing on precision oncology treatments. Leadership is provided by CEO Cecilia De Leeuw, with activities primarily based in Europe.
C-RAD's top competitors include Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics and Averto Medical.
C-RAD offers Catalyst⁺ HD, Catalyst⁺, and Sentinel 4DCT.
C-RAD has made 1 acquisition, including MedAustron.
C-RAD has 4 investors. Key investors include TIN Fonder, Berenberg, Humle Kapitalförvaltning, and Alfred Berg.